We believe this site might serve you best::

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Anti-ACTIVE® MAPK, JNK and p38 Polyclonal Antibodies and Anti-ACTIVE® Qualified...

Anti-ACTIVE® MAPK, JNK and p38 Polyclonal Antibodies and Anti-ACTIVE® Qualified Secondary Antibody Conjugate Technical Bulletin

Instructions for Use of Product(s)
V1211, V8031, V7931, V7932
Literature # TB262

Promega has developed polyclonal antibodies (pAb) to three members of the Mitogen-Activated Protein Kinase (MAPK) superfamily of enzymes. These enzymes, which play important roles in signal transduction in eukaryotic cells, are MAPK, p38 and JNK. These kinases have interconnected roles in a cascade of signal transduction reactions. The Anti-ACTIVE® pAbs are specific for the dually phosphorylated active forms of MAPK, p38 and JNK and provide tools to measure more accurately activation of these enzymes.

Printed in USA. Revised 1/12.

Choose your country

Americas

Brazil
Brazil
Canada
Canada
United States
United States

Pacific Asia

Australia
Australia
India
India
Japan
Japan
Korea, Republic of
Korea, Republic of
Singapore
Singapore

Europe

Austria
Austria
Belgium
Belgium
Denmark
Denmark
Estonia
Estonia
Finland
Finland
France
France
Germany
Germany
Iceland
Iceland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Norway
Norway
Poland
Poland
Spain
Spain
Sweden
Sweden
Switzerland
Switzerland
United Kingdom
United Kingdom